Medtronic wins FDA approval for adjustable spine-pain implant
washingtonpost.com/business/2024/04/26/medtronic-spinal-cord-stimulatorMedtronic said Friday that the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain, a bid to expand into a patient population that relies heavily on medications like opioids. The new device works by delivering an electrical pulse to the spinal cord, interrupting pain signals before they reach the brain in patients suffering from…
This story appeared on washingtonpost.com, .